Investigators at National Cancer Institute (NCI) Detail Findings in Solid Cancer (First-in-human Phase 1 Clinical Trial of Anti-core 1 O-glycans Targeting Monoclonal Antibody Neo-201 In Treatment-refractory Solid Tumors)

  • William Figg

Press/Media

Period17 May 2023

Media coverage

1

Media coverage

  • TitleInvestigators at National Cancer Institute (NCI) Detail Findings in Solid Cancer (First-in-human Phase 1 Clinical Trial of Anti-core 1 O-glycans Targeting Monoclonal Antibody Neo-201 In Treatment-refractory Solid Tumors)
    Media name/outletNewsRx Hematology Daily
    Country/TerritoryUnited States
    Date17/05/23
    URLmetabase.moreover.com/noarticleurl?type=psh&lni=6882-F0C1-JBSP-119S-00000-00
    PersonsWilliam Figg
View all 1
View less

Related content